Standard methods of sample collection, reference standards, universal cut-off values for diagnostic tests, and standard operating procedures (SOP) are urgently needed for most advanced AD biomarkers (CSF core biomarkers, Aβ-PET, FDG-PET, and tau-PET). The gene discussed is MAPT; the disease is Alzheimer disease.